首页> 外文OA文献 >Joint regeneration mechanisms in red-spotted newts (Notophthalmus viridescens viridescens)
【2h】

Joint regeneration mechanisms in red-spotted newts (Notophthalmus viridescens viridescens)

机译:红斑new的联合再生机制(线虫绿绿)

摘要

Lesions of articular cartilage are still leading to irreversible degenerative joint diseases including osteoarthritis (OA). Aside pain, the disease results in loss of function of the affected joint and severe disability and a substantial reduction of quality of life of the affected patient. The human does not have the endogenous capacity to restore the structure and the function of the osteoarthritic knee joint damage. In contrast, animals such as the red-spotted newt (Notophthalmus viridescens viridescens) are able to repair complete organs and tissues including joints after artificial damage by collagenase treatment and surgery. The underlying mechanisms of this regenerative process can be further investigated by cDNA microarray showing distinct genes, which were differentially upregulated in both models for OA.Based on these results, in this doctoral project, the genes, that were found to be upregulated in the cDNA microarray study and additional genes from the vitamin A pathway, and the innate immune system, both known to be involved in repair processes were selected for real-time PCR analysis to primarily quantify their deregulation status. Here, real-time PCR study confirmed the deregulation of distinct molecules including secreted protein acidic and rich in cysteine (SPARC), periostin (POSTN), decorin (DCN), complement factor B (CFB), tenascin-C (TN-C), toll-like receptor 2 (TLR2), and retinoic acid receptor responder 1 (RARRES1). Among these selected factors, TN-C was the most interesting one, because the deregulation of this matricellular protein was the most prominent among the other selected candidates. IHC analysis revealed that the spatial expression of TN-C during the knee joint regeneration process was unique in each OA model. At day 10 and 20 after surgery treatment, TN-C appeared in the defected articular cartilage of the treated knee joints in two of three analyzed animals. In contrast, in the animals of the collagenase model, the TN-C expression was absent in the defected articular cartilage. It supported the idea of a differential initiation of the repair process depending on the type of the damage inflicted. The appearance of this matricellular protein in the defected articular cartilage in the animals of the surgery model can be seen as a part of an inflammatory response during the injury process. At day 20 after treatment, undifferentiated tissue emerged in the regenerating newt knee joint of all analyzed animals. TN-C was expressed abundantly in this tissue, which is a further indication of its involvement in the knee joint regeneration. At day 40 after treatment, all of the three analyzed animals in the surgery model and one animal of the two analyzed animals in the collagenase model demonstrated expression of TN-C in the newly formed articular cartilage. Here, TN-C could promote the formation of this tissue. In the regenerating knee joint of one analyzed animal in the surgically-treated animals, TN-C appeared only in the newly formed articular cartilage, but it was absent in the old-defected cartilage. In order to investigate whether the involvement of TN-C was functionally important for the knee joint regeneration process, gene silencing experiments were conducted in newt primary chondrocytes using TN-C esiRNAs in vitro, introduced into the primary newt chondrocytes by nucleofection. In two independent experiments, TN-C expression could be reduced to 0.55-fold (45% reduction) and 0.29-fold (71% reduction), the effect of one-time TN-C gene silencing on regenerative capacity of newt chondrocytes with respect to migration and adhesive capacity of these cells did not result in a statistically significant effect. In addition, in order to elucidate the effect of TN-C knockdown on other dysregulated candidate genes including SPARC and DCN, relative quantification of the transcription product of both genes was performed. The result of the measurement demonstrated that TN-C knockdown in newt chondrocytes did not alter the expression levels of these molecules. SPARC, another prominent candidate gene, which was selected from the cDNA microarray, was present in several tissues in untreated newt legs including osteocytes, articular cartilage, blood vessels and skin. As SPARC is known to be important for the normal function of these tissues, in the regenerating newt knee joint already at day 20 after surgery treatment, this matricellular protein was localized abundantly in distinct areas in the skeletal muscle and periosteum. Of note, this expression was not directly related to the regeneration process since these tissues were not primarily damaged by the surgical treatment.Similar to the results obtained from the TN-C and SPARC experiments, several other matrix repair associated molecules were found to be upregulated and expressed at different time points during the newt knee joint regeneration process, providing interesting new insights into this fascinating phenomenon. However, the experiments of this doctoral thesis also showed the still existing limitations of an experimental approach in an organism, for which the technical systems still need to be fully established.
机译:关节软骨病变仍导致不可逆的退行性关节疾病,包括骨关节炎(OA)。除了疼痛之外,该疾病还导致受影响的关节功能丧失和严重的残疾,并大大降低了受影响患者的生活质量。人不具有恢复骨关节炎膝关节损伤的结构和功能的内生能力。相反,诸如红点collagen(Notophthalmus viridescens viridescens)之类的动物在通过胶原酶治疗和手术受到人工损伤后,能够修复包括器官在内的完整器官和组织。可以通过cDNA微阵列进一步研究这种再生过程的潜在机制,该芯片显示了两种基因在OA模型中差异上调的独特基因。基于这些结果,在本博士项目中,发现了在cDNA中上调的基因我们选择了芯片研究以及来自维生素A途径的其他基因以及先天免疫系统(已知都与修复过程有关)进行实时PCR分析,从而主要量化了它们的失控状态。在这里,实时PCR研究证实了不同分子的失控,包括酸性分泌蛋白和富含半胱氨酸(SPARC),骨膜素(POSTN),核心蛋白聚糖(DCN),补体因子B(CFB),腱糖蛋白C(TN-C) ,toll​​样受体2(TLR2)和视黄酸受体应答剂1(RARRES1)。在这些选择的因素中,TN-C是最有趣的因素,因为在其他选择的候选物质中,这种基质细胞蛋白的去调节作用最为明显。 IHC分析表明,在每个OA模型中,TN-C在膝关节再生过程中的空间表达都是唯一的。在手术治疗后的第10天和第20天,TN-C出现在三只分析的动物中的两只中,被治疗的膝关节的关节软骨缺损。相反,在胶原酶模型的动物中,在缺损的关节软骨中不存在TN-C表达。它支持根据所造成损害的类型以不同方式启动修复过程的想法。该基质细胞蛋白在手术模型动物的关节软骨缺损中的出现可以看作是损伤过程中炎症反应的一部分。治疗后第20天,所有分析动物的再生new关节中均出现未分化的组织。 TN-C在该组织中大量表达,这进一步表明了其参与膝关节再生。在治疗后第40天,手术模型中的所有三只被分析的动物和胶原酶模型中的两只被分析的动物中的一只都证明了新形成的关节软骨中TN-C的表达。在此,TN-C可以促进该组织的形成。在接受手术治疗的动物中,一只分析过的动物的膝关节再生中,TN-C仅出现在新形成的关节软骨中,而旧变形的软骨中则不存在。为了研究TN-C的参与对于膝关节再生过程是否在功能上很重要,我们在体外使用TN-C esiRNA在new原代软骨细胞中进行了基因沉默实验,并通过核转染将其引入原代new软骨细胞中。在两个独立的实验中,TN-C的表达可以降低到0.55倍(降低45%)和0.29倍(降低71%),这是一次性TN-C基因沉默对new软骨细胞再生能力的影响这些细胞的迁移和粘附能力没有导致统计学上显着的影响。此外,为了阐明TN-C敲低对其他失调的候选基因(包括SPARC和DCN)的影响,对这两个基因的转录产物进行了相对定量。测量结果表明new软骨细胞中的TN-C敲低不会改变这些分子的表达水平。 SPARC是另一个显着的候选基因,它选自cDNA微阵列,存在于未经处理的new腿的几种组织中,包括骨细胞,关节软骨,血管和皮肤。由于已知SPARC对这些组织的正常功能很重要,因此在手术治疗后的第20天,在再生new关节中,这种基质细胞蛋白大量分布在骨骼肌和骨膜的不同区域。值得注意的是,该表达与再生过程没有直接关系,因为这些组织并未受到手术治疗的主要损害。与TN-C和SPARC实验获得的结果相似,发现其他几种基质修复相关分子也被上调并在the膝关节再生过程中的不同时间点表达,为这一迷人现象提供了有趣的新见解。然而,该博士论文的实验还显示了生物中实验方法仍然存在的局限性,为此仍需要完全建立技术体系。

著录项

  • 作者

    Susanto Sony Adhi;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号